VALMT Stock Analysis: Valmet | HE
Specialty Industrial Machinery | HE, Finland | Market Cap: 5.092m EUR | 12M Return: -2.4% | FI4000074984 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.9M
EPS Trend: -87.0%
Qual. Beats: 0
Rev. Trend: -82.0%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Valmet Oyj is a Finnish industrial technology company that supplies process technologies, automation systems, and lifecycle services to the pulp, paper, packaging, tissue, bioenergy, and broader process industries. It reports through two segments: Process Performance Solutions (flow control, valves, pumps, automation, and digital/IIoT offerings) and Biomaterial Solutions and Services (complete production lines, process islands, rebuilds, and aftermarket services).
The business model is a hybrid of project-based capital equipment deliveries and a recurring aftermarket and services stream covering rebuilds, upgrades, conversions, maintenance, remote monitoring, and predictive maintenance. Industrial OEMs in this sector typically derive a meaningful share of revenue from parts and services over the multi-decade operating life of installed equipment, which supports more stable cash flow than new-build sales alone.
Valmet is headquartered in Espoo, Finland, and traces its origins to 1750. It operates across North America, Latin America, EMEA, China, and Asia-Pacific, and is classified as a mid-cap Industrials stock (GICS Industrial Machinery & Supplies & Components). Finland is a notable global hub for pulp and paper machinery, hosting several leading process technology suppliers.
- China pulp and paper equipment orders remain subdued amid weak Asian demand
- Services and automation revenue growth supports margin expansion
- Energy transition drives bioenergy and circularity capex demand
| Net Income: 300.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.71 > 1.0 |
| NWC/Revenue: 6.66% < 20% (prev 5.05%; Δ 1.61% < -1%) |
| CFO/TA 0.06 > 3% & CFO 384.0m > Net Income 300.0m |
| Net Debt (1.13b) to EBITDA (676.0m): 1.68 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (187.5m) vs 12m ago 1.80% < -2% |
| Gross Margin: 25.38% > 18% (prev 28.11%; Δ -2.73% > 0.5%) |
| Asset Turnover: 79.11% > 50% (prev 77.82%; Δ 1.30% > 0%) |
| Interest Coverage Ratio: 6.91 > 6 (EBIT TTM 470.0m / Interest Expense TTM 68.0m) |
| A: 0.05 (Total Current Assets 2.99b - Total Current Liabilities 2.63b) / Total Assets 6.73b |
| B: 0.15 (Retained Earnings 1.03b / Total Assets 6.73b) |
| C: 0.07 (EBIT TTM 470.0m / Avg Total Assets 6.74b) |
| D: 0.59 (Book Value of Equity 2.49b / Total Liabilities 4.23b) |
| Altman-Z'' = 1.93 = BBB |
| DSRI: 1.04 (Receivables 1.12b/1.06b, Revenue 5.33b/5.25b) |
| GMI: 1.11 (GM 28.11% / 25.38%) |
| AQI: 0.97 (AQ_t 0.45 / AQ_t-1 0.46) |
| SGI: 1.02 (Revenue 5.33b / 5.25b) |
| TATA: -0.01 (NI 300.0m - CFO 384.0m) / TA 6.73b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of August 24, 2026, the stock is trading at EUR 27.78 with a total of 257,225 shares traded. Over the past week, the price has changed by +0.51%, over one month by +26.04%, over three months by +20.26% and over the past year by -2.41%.
Current recommended Stop Loss: 27.10 (which is 2.4% or 1.2 ATR below the current price).
Valmet has no consensus analysts rating.
P/E Trailing = 16.9571
P/S = 0.9552
P/B = 2.0434
Revenue TTM = 5.33b EUR
EBIT TTM = 470.0m EUR
EBITDA TTM = 676.0m EUR
Long Term Debt = 1.06b EUR (from longTermDebt, last quarter)
Short Term Debt = 392.0m EUR (from shortTermDebt, last quarter)
Debt = 1.75b EUR (from shortLongTermDebtTotal, last quarter) + Leases 173.0m
Net Debt = 1.13b EUR (calculated: Debt 1.75b - CCE 620.0m)
Enterprise Value = 6.23b EUR (5.09b + Debt 1.75b - CCE 620.0m)
Interest Coverage Ratio = 6.91 (Ebit TTM 470.0m / Interest Expense TTM 68.0m)
EV/FCF = 20.96x (Enterprise Value 6.23b / FCF TTM 297.0m)
FCF Yield = 4.77% (FCF TTM 297.0m / Enterprise Value 6.23b)
FCF Margin = 5.57% (FCF TTM 297.0m / Revenue TTM 5.33b)
Net Margin = 5.63% (Net Income TTM 300.0m / Revenue TTM 5.33b)
Gross Margin = 25.38% ((Revenue TTM 5.33b - Cost of Revenue TTM 3.98b) / Revenue TTM)
Gross Margin QoQ = 27.30% (prev 24.92%)
Tobins Q-Ratio = 0.92 (Enterprise Value 6.23b / Total Assets 6.73b)
Interest Expense / Debt = 3.88% (Interest Expense 68.0m / Debt 1.75b)
Taxrate = 29.05% (122.0m / 420.0m)
NOPAT = 333.5m (EBIT 470.0m * (1 - 29.05%))
Current Ratio = 1.13 (Total Current Assets 2.99b / Total Current Liabilities 2.63b)
Debt / Equity = 0.70 (Debt 1.75b / totalStockholderEquity, last quarter 2.49b)
Debt / EBITDA = 1.68 (Net Debt 1.13b / EBITDA 676.0m)
Debt / FCF = 3.82 (Net Debt 1.13b / FCF TTM 297.0m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.45% (Net Income 300.0m / Total Assets 6.73b)
RoE = 12.07% (Net Income TTM 300.0m / Total Stockholder Equity 2.49b)
RoCE = 13.24% (EBIT 470.0m / Capital Employed (Equity 2.49b + L.T.Debt 1.06b))
RoIC = 7.89% (NOPAT 333.5m / Invested Capital 4.22b)
WACC = 6.76% (E(5.09b)/V(6.85b) * Re(8.14%) + D(1.75b)/V(6.85b) * Rd(3.88%) * (1-Tc(0.29)))
Discount Rate = 8.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 52.86 | Cagr: 0.81%
[DCF] Terminal Value 73.10% ; FCFF base≈370.2m ; Y1≈324.6m ; Y5≈262.3m
[DCF] Fair Price = 16.70 (EV 4.21b - Net Debt 1.13b = Equity 3.08b / Shares 184.2m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -87.01 | EPS CAGR: -9.60% | SUE: -0.11 | # QB: 0
Revenue Correlation: -82.04 | Revenue CAGR: -1.90% | SUE: 1.76 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.59 | Chg30d=+5.80% | Revisions=+50% | Analysts=5
EPS current Year (2026-12-31): EPS=2.20 | Chg30d=+12.88% | Revisions=+57% | GrowthEPS=+20.6% | GrowthRev=+2.8%
EPS next Year (2027-12-31): EPS=2.38 | Chg30d=+13.92% | Revisions=+57% | GrowthEPS=+8.2% | GrowthRev=+1.4%
[Analyst] Revisions Ratio: +79% (up=11, down=0)